相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Self-assembled pH-responsive hyaluronic acid-g-poly(L-histidine) copolymer micelles for targeted intracellular delivery of doxorubicin
Lipeng Qiu et al.
ACTA BIOMATERIALIA (2014)
CD44v6 Is a Marker of Constitutive and Reprogrammed Cancer Stem Cells Driving Colon Cancer Metastasis
Matilde Todaro et al.
CELL STEM CELL (2014)
Antibody Against CD44s Inhibits Pancreatic Tumor Initiation and Postradiation Recurrence in Mice
Ling Li et al.
GASTROENTEROLOGY (2014)
A Novel CD44-binding Peptide from the Pro-Matrix Metalloproteinase-9 Hemopexin Domain Impairs Adhesion and Migration of Chronic Lymphocytic Leukemia (CLL) Cells
Estefania Ugarte-Berzal et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Preclinical evaluation of 89Zr-labeled anti-CD44 monoclonal antibody RG7356 in mice and cynomolgus monkeys Prelude to Phase 1 clinical studies
Danielle J. Vugts et al.
MABS (2014)
Tumor targeting profiling of hyaluronan-coated lipid based-nanoparticles
Shoshy Mizrahy et al.
NANOSCALE (2014)
Stem cell CD44v isoforms promote intestinal cancer formation in Apc(min) mice downstream of Wnt signaling
J. Zeilstra et al.
ONCOGENE (2014)
DNA Aptamers against Exon v10 of CD44 Inhibit Breast Cancer Cell Migration
Joji Iida et al.
PLOS ONE (2014)
MicroRNA-328 Inhibits Renal Tubular Cell Epithelial-to-Mesenchymal Transition by Targeting the CD44 in Pressure-Induced Renal Fibrosis
Cheng-Hsien Chen et al.
PLOS ONE (2014)
Multifunctional Tumor-Targeting Nanocarriers Based on Hyaluronic Acid-Mediated and pH-Sensitive Properties for Efficient Delivery of Docetaxel
Shuangshuang Song et al.
PHARMACEUTICAL RESEARCH (2014)
In vivo characterization of the novel CD44v6-targeting Fab fragment AbD15179 for molecular imaging of squamous cell carcinoma: a dual-isotope study
Anna-Karin Haylock et al.
EJNMMI RESEARCH (2014)
CD44v6-targeted T cells mediate potent antitumor effects against acute myeloid leukemia and multiple myeloma
Monica Casucci et al.
BLOOD (2013)
Targeted Nanomedicine for Suppression of CD44 and Simultaneous Cell Death Induction in Ovarian Cancer: An Optimal Delivery of siRNA and Anticancer Drug
Vatsal Shah et al.
CLINICAL CANCER RESEARCH (2013)
CD44 integrates signaling in normal stem cell, cancer stem cell and (pre)metastatic niches
Karin Williams et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2013)
MicroRNA-143 Inhibits Migration and Invasion of Human Non-Small-Cell Lung Cancer and Its Relative Mechanism
Qingping Ma et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2013)
Near-Infrared Fluorescence Molecular Imaging of Ductal Carcinoma In Situ with CD44v6-Specific Antibodies in Mice: A Preclinical Study
Jeroen F. Vermeulen et al.
MOLECULAR IMAGING AND BIOLOGY (2013)
Targeting chronic lymphocytic leukemia cells with a humanized monoclonal antibody specific for CD44
Suping Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Opposing effects of high- and low-molecular weight hyaluronan on CXCL12-induced CXCR4 signaling depend on CD44
K. Fuchs et al.
CELL DEATH & DISEASE (2013)
Global Quantitative Phosphoproteome Analysis of Human Tumor Xenografts Treated with a CD44 Antagonist
Stefan Weigand et al.
CANCER RESEARCH (2012)
Hyaluronic acid-based nanocarriers for intracellular targeting: Interfacial interactions with proteins in cancer
Ki Young Choi et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2012)
CD44: a validated target for improved delivery of cancer therapeutics
Sukhen C. Ghosh et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2012)
A phase II study of a urokinase-derived peptide (A6) in the treatment of persistent or recurrent epithelial ovarian, fallopian tube, or primary peritoneal carcinoma: A Gynecologic Oncology Group study
Michael A. Gold et al.
GYNECOLOGIC ONCOLOGY (2012)
A 17-residue Sequence from the Matrix Metalloproteinase-9 (MMP-9) Hemopexin Domain Binds α4β1 Integrin and Inhibits MMP-9-induced Functions in Chronic Lymphocytic Leukemia B Cells
Estefania Ugarte-Berzal et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Targeted Expression of miR-34a Using the T-VISA System Suppresses Breast Cancer Cell Growth and Invasion
Laisheng Li et al.
MOLECULAR THERAPY (2012)
CD44 Variant Regulates Redox Status in Cancer Cells by Stabilizing the xCT Subunit of System xc- and Thereby Promotes Tumor Growth
Takatsugu Ishimoto et al.
CANCER CELL (2011)
FKBPL and Peptide Derivatives: Novel Biological Agents That Inhibit Angiogenesis by a CD44-Dependent Mechanism
Andrea Valentine et al.
CLINICAL CANCER RESEARCH (2011)
Hyaluronan-CD44 interactions as potential targets for cancer therapy
Suniti Misra et al.
FEBS JOURNAL (2011)
c-Met Is a Marker of Pancreatic Cancer Stem Cells and Therapeutic Target
Chenwei Li et al.
GASTROENTEROLOGY (2011)
Head neck squamous cell carcinoma c-Met+ cells display cancer stem cell properties and are responsible for cisplatin-resistance and metastasis
Shuyang Sun et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
CD44v6 Coordinates Tumor Matrix-triggered Motility and Apoptosis Resistance
Thorsten Jung et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
A6 Peptide Activates CD44 Adhesive Activity, Induces FAK and MEK Phosphorylation, and Inhibits the Migration and Metastasis of CD44-Expressing Cells
Randolph S. Piotrowicz et al.
MOLECULAR CANCER THERAPEUTICS (2011)
The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44
Can Liu et al.
NATURE MEDICINE (2011)
miR-199a-3p targets CD44 and reduces proliferation of CD44 positive hepatocellular carcinoma cell lines
Jon C. Henry et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
The miR-34 family in cancer and apoptosis
H. Hermeking
CELL DEATH AND DIFFERENTIATION (2010)
CD44, a therapeutic target for metastasising tumours
Veronique Orian-Rousseau
EUROPEAN JOURNAL OF CANCER (2010)
A CD44v6 peptide reveals a role of CD44 in VEGFR-2 signaling and angiogenesis
Martina Tremmel et al.
BLOOD (2009)
MicroRNAs and Cancer: Short RNAs Go a Long Way
Andrea Ventura et al.
CELL (2009)
Emerging roles of microRNAs as molecular switches in the integrated circuit of the cancer cell
Georgia Sotiropoulou et al.
RNA (2009)
CD44v6 Dependence of Premetastatic Niche Preparation by Exosomes
Thorsten Jung et al.
NEOPLASIA (2009)
MicroRNAs - the micro steering wheel of tumour metastases
Milena S. Nicoloso et al.
NATURE REVIEWS CANCER (2009)
Cancer stem cells: markers or biomarkers?
Wendy A. Woodward et al.
CANCER AND METASTASIS REVIEWS (2008)
Deletion of the WNT target and cancer stem cell marker CD44 in Apc(Min/ plus ) mice attenuates intestinal tumorigenesis
Jurrit Zeilstra et al.
CANCER RESEARCH (2008)
A phase 2, randomized, double-blind, placebo-controlled trial of clinical activity and safety of subcutaneous Å6 in women with asymptomatic CA125 progression after first-line chemotherapy of epithelial ovarian cancer
Sharad A. Ghamande et al.
GYNECOLOGIC ONCOLOGY (2008)
Preparation and characterization of HA-PEG-PCL intelligent core-corona nanoparticles for delivery of doxorubicin
Awesh Kumar Yadav et al.
JOURNAL OF DRUG TARGETING (2008)
Phase I trial with the CD44v6-targeting immunoconjugate bivatuzumab mertansine in head and neck squamous cell carcinoma
Herbert Riechelmann et al.
ORAL ONCOLOGY (2008)
Targeting CD44v6 expressed in head and neck squamous cell carcinoma: Preclinical characterization of an In-111-labeled monoclonal antibody
Karl Sandstrom et al.
TUMOR BIOLOGY (2008)
Exogenous mesenchymal stem cells localize to the kidney by means of CD44 following acute tubular injury
M. B. Herrera et al.
KIDNEY INTERNATIONAL (2007)
Hepatocyte growth factor-induced Ras activation requires ERM proteins linked to both CD44v6 and F-Actin
Veronique Orian-Rousseau et al.
MOLECULAR BIOLOGY OF THE CELL (2007)
Immuno-PET of undifferentiated thyroid carcinoma with radioiodine-labelled antibody cMAb U36: application to antibody tumour uptake studies
Marc-Andre Fortin et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2007)
MicroRNA signatures in human cancers
George A. Calin et al.
NATURE REVIEWS CANCER (2006)
A phase I dose escalation study with anti-CD44v6 bivatuzumab mertansine in patients with incurable squamous cell carcinoma of the head and neck or esophagus
Bernard M. Tijink et al.
CLINICAL CANCER RESEARCH (2006)
Targeting of CD44 eradicates human acute myeloid leukemic stem cells
Liqing Jin et al.
NATURE MEDICINE (2006)
Performance of immuno-positron emission tomography with zirconium-89-labeled chimeric monoclonal antibody U36 in the detection of lymph node metastases in head and neck cancer patients
PKE Börjesson et al.
CLINICAL CANCER RESEARCH (2006)
A five-amino-acid peptide blocks Met- and Ron-dependent cell migration
A Matzke et al.
CANCER RESEARCH (2005)
An inducible caspase 9 safety switch for T-cell therapy
KC Straathof et al.
BLOOD (2005)
CD44 and hyaluronic acid cooperate with SDF-1 in the trafficking of human CD34+ stem/progenitor cells to bone marrow
A Avigdor et al.
BLOOD (2004)
Loading mitomycin C inside long circulating hyaluronan targeted nano-liposomes increases its antitumor activity in three mice tumor models
D Peer et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
Determination and modeling of kinetics of cancer cell killing by doxorubicin and doxorubicin encapsulated in targeted liposomes
RE Eliaz et al.
CANCER RESEARCH (2004)
Identification of an active site on the laminin α5 chain globular domain that binds to CD44 and inhibits malignancy
S Hibino et al.
CANCER RESEARCH (2004)
Safety, pharmacokinetics, immunogenicity, and biodistribution of 186Re-labeled humanized monoclonal antibody BIWA 4 (bivatuzumab) in patients with early-stage breast cancer
M Koppe et al.
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS (2004)
Transforming growth factor-beta facilitates breast carcinoma metastasis by promoting tumor cell survival
Q Yu et al.
CLINICAL & EXPERIMENTAL METASTASIS (2004)
Transferrin-containing, cyclodextrin polymer-based particles for tumor-targeted gene delivery
NC Bellocq et al.
BIOCONJUGATE CHEMISTRY (2003)
Safety, biodistribution, pharmacokinetics, and immunogenicity of 99mTc-labeled humanized monoclonal antibody BIWA 4 (bivatuzumab) in patients with squamous cell carcinoma of the head and neck
DR Colnot et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2003)
A urokinase-derived peptide (Å6) increases survival of mice bearing orthotopically grown prostate cancer and reduces lymph node metastasis
DD Boyd et al.
AMERICAN JOURNAL OF PATHOLOGY (2003)
CD44: From adhesion molecules to signalling regulators
H Ponta et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2003)
CD44 is required for two consecutive steps in HGF/c-Met signaling
V Orian-Rousseau et al.
GENES & DEVELOPMENT (2002)
Hyaluronan oligosaccharides inhibit anchorage-independent growth of tumor cells by suppressing the phosphoinositide 3-kinase/Akt cell survival pathway
S Ghatak et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Tumor targeting properties of monoclonal antibodies with different affinity for target antigen CD44V6 in nude mice bearing head-and-neck cancer xenografts
I Verel et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
CD44 anchors the assembly of matrilysin/MMP-7 with heparin-binding epidermal growth factor precursor and ErbB4 and regulates female reproductive organ remodeling
WH Yu et al.
GENES & DEVELOPMENT (2002)
Automated selection of anti-protein aptamers
JC Cox et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2001)
Soluble CD44 inhibits melanoma tumor growth by blocking cell surface CD44 binding to hyaluronic acid
T Ahrens et al.
ONCOGENE (2001)
Cross-linked hyaluronic acid hydrogel films: new biomaterials for drug delivery
Y Luo et al.
JOURNAL OF CONTROLLED RELEASE (2000)
Perturbation of hyaluronan interactions by soluble CD44 inhibits growth of murine mammary carcinoma cells in ascites
RM Peterson et al.
AMERICAN JOURNAL OF PATHOLOGY (2000)
分享论文
